Targeting CXCR1/2 in the first multicenter, double-blinded, randomized trial in autologous islet transplant recipients.
Witkowski P, Wijkstrom M, Bachul PJ, Morgan KA, Levy M, Onaca N, Chaidarun SS, Gardner T, Shapiro AMJ, Posselt A, Ahmad SA, Daffonchio L, Ruffini PA, Bellin MD.
Witkowski P, et al. Among authors: shapiro amj.
Am J Transplant. 2021 Nov;21(11):3714-3724. doi: 10.1111/ajt.16695. Epub 2021 Jun 23.
Am J Transplant. 2021.
PMID: 34033222
Free article.
Clinical Trial.